Cementos Bio Bio Income Statement

Financials in millions CLP. Fiscal year is January - December.

Millions CLP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	370,540	359,565	349,104	334,004	289,468
Revenue Growth (YoY)	3.05%	3.00%	4.52%	15.38%	19.33%
Cost of Revenue	227,354	222,102	219,413	228,479	186,287
Gross Profit	143,187	137,462	129,692	105,525	103,181
Selling, General & Admin	98,716	97,800	94,685	94,110	86,095
Other Operating Expenses	-563.18	445.7	120.09	-	-
Operating Expenses	98,153	98,245	94,805	94,110	86,095
Operating Income	45,034	39,217	34,887	11,415	17,086
Interest Expense	-8,981	-10,708	-14,353	-11,141	-3,561
Interest & Investment Income	1,763	1,490	1,210	1,063	598.99
Currency Exchange Gain (Loss)	385.21	3,877	434.34	-1,311	1,425
Other Non Operating Income (Expenses)	1,136	1,260	3,574	1,954	2,114
EBT Excluding Unusual Items	39,337	35,136	25,752	1,980	17,662
Gain (Loss) on Sale of Assets	217.71	5,265	556.51	3,427	8,655
Asset Writedown	-287.57	-508.61	-584.07	-2,550	-988.27
Other Unusual Items	-	-	-	-	685.41
Pretax Income	39,671	40,970	26,622	5,635	33,911
Income Tax Expense	6,576	8,571	3,812	-4,926	6,885
Earnings From Continuing Operations	33,095	32,399	22,809	10,561	27,026
Minority Interest in Earnings	-7.17	28.34	-12.25	-1.13	-146.9
Net Income	33,088	32,427	22,797	10,560	26,879
Net Income to Common	33,088	32,427	22,797	10,560	26,879
Net Income Growth	2.04%	42.24%	115.88%	-60.71%	95.30%
Shares Outstanding (Basic)	264	264	264	264	264
Shares Outstanding (Diluted)	264	264	264	264	264
EPS (Basic)	125.23	122.73	86.28	39.97	101.73
EPS (Diluted)	125.23	122.73	86.28	39.97	101.73
EPS Growth	2.04%	42.24%	115.88%	-60.71%	95.30%
Free Cash Flow	46,673	54,336	24,086	9,374	3,860
Free Cash Flow Per Share	176.64	205.65	91.16	35.48	14.61
Dividend Per Share	-	80.000	36.000	12.000	48.000
Dividend Growth	-	122.22%	200.00%	-75.00%	14.29%
Gross Margin	38.64%	38.23%	37.15%	31.59%	35.64%
Operating Margin	12.15%	10.91%	9.99%	3.42%	5.90%
Profit Margin	8.93%	9.02%	6.53%	3.16%	9.29%
Free Cash Flow Margin	12.60%	15.11%	6.90%	2.81%	1.33%
EBITDA	59,900	53,550	48,082	24,159	30,270
EBITDA Margin	16.17%	14.89%	13.77%	7.23%	10.46%
D&A For EBITDA	14,866	14,332	13,195	12,744	13,184
EBIT	45,034	39,217	34,887	11,415	17,086
EBIT Margin	12.15%	10.91%	9.99%	3.42%	5.90%
Effective Tax Rate	16.58%	20.92%	14.32%	-	20.30%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.